The world is on alert for the new omicron variant and in the search for weapons to fight covid-19, advisers to the United States Food and Drug Administration, FDA, voted to recommend the emergency use authorization of the pill from Merck and Ridgeback Biotherapeutics.
Will it finally be authorized?